Similar Articles
1491 Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
1492 Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
1493 Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease
1494 Hepatic encephalopathy before and neurological complications after liver transplantation have no impact on the employment status 1 year after transplantation
1495 Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
1496 CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma
1497 Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass
1498 Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
1499 Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era
1500 Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA